These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 31703388)
1. South African Abietane Diterpenoids and Their Analogs as Potential Antimalarials: Novel Insights from Hybrid Computational Approaches. Musyoka T; Bishop ÖT Molecules; 2019 Nov; 24(22):. PubMed ID: 31703388 [TBL] [Abstract][Full Text] [Related]
2. Structure Based Docking and Molecular Dynamic Studies of Plasmodial Cysteine Proteases against a South African Natural Compound and its Analogs. Musyoka TM; Kanzi AM; Lobb KA; Tastan Bishop Ö Sci Rep; 2016 Mar; 6():23690. PubMed ID: 27030511 [TBL] [Abstract][Full Text] [Related]
3. Identification of Selective Novel Hits against Nyamai DW; Tastan Bishop Ö Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245 [TBL] [Abstract][Full Text] [Related]
4. Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design. Musyoka TM; Njuguna JN; Tastan Bishop Ö Malar J; 2019 May; 18(1):159. PubMed ID: 31053072 [TBL] [Abstract][Full Text] [Related]
5. Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study. Boateng RA; Tastan Bishop Ö; Musyoka TM Malar J; 2020 Nov; 19(1):442. PubMed ID: 33256744 [TBL] [Abstract][Full Text] [Related]
6. Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012). Pérez B; Teixeira C; Gomes JR; Gomes P Curr Med Chem; 2013; 20(25):3049-68. PubMed ID: 23514416 [TBL] [Abstract][Full Text] [Related]
8. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region. Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224 [TBL] [Abstract][Full Text] [Related]
9. Identification of first-in-class plasmodium OTU inhibitors with potent anti-malarial activity. Siyah P; Akgol S; Durdagi S; Kocabas F Biochem J; 2021 Sep; 478(18):3445-3466. PubMed ID: 34486667 [TBL] [Abstract][Full Text] [Related]
10. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets. Qidwai T Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296 [TBL] [Abstract][Full Text] [Related]
11. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. Thillainayagam M; Malathi K; Ramaiah S J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266 [TBL] [Abstract][Full Text] [Related]
12. Characterization of amino acid variation at strategic positions in parasite and human proteases for selective inhibition of falcipains in Plasmodium falciparum. Goh LL; Sim TS Biochem Biophys Res Commun; 2005 Sep; 335(3):762-70. PubMed ID: 16095562 [TBL] [Abstract][Full Text] [Related]
13. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors. Chaudhary M; Singh V; Anvikar AR; Sahi S Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897 [TBL] [Abstract][Full Text] [Related]
14. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics. Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475 [TBL] [Abstract][Full Text] [Related]
15. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1). Kumar A; Dhar SK; Subbarao N J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440 [TBL] [Abstract][Full Text] [Related]
16. Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures. Hernández-González JE; Salas-Sarduy E; Hernández Ramírez LF; Pascual MJ; Álvarez DE; Pabón A; Leite VBP; Pascutti PG; Valiente PA Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2911-2923. PubMed ID: 30253205 [TBL] [Abstract][Full Text] [Related]
17. Establishing Computational Approaches Towards Identifying Malarial Allosteric Modulators: A Case Study of Amusengeri A; Astl L; Lobb K; Verkhivker GM; Tastan Bishop Ö Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717270 [TBL] [Abstract][Full Text] [Related]
18. Design, molecular docking, drug-likeness, and molecular dynamics studies of 1,2,4-trioxane derivatives as novel Ghosh S; Chetia D; Gogoi N; Rudrapal M BioTechnologia (Pozn); 2021; 102(3):257-275. PubMed ID: 36606151 [TBL] [Abstract][Full Text] [Related]
19. In silico study of M18 aspartyl amino peptidase (M18AAP) of Plasmodium vivax as an antimalarial drug target. Rout S; Mahapatra RK Bioorg Med Chem; 2019 Jun; 27(12):2553-2571. PubMed ID: 30929948 [TBL] [Abstract][Full Text] [Related]
20. Multicomplex-based pharmacophore modeling in conjunction with multi-target docking and molecular dynamics simulations for the identification of Manhas A; Lone MY; Jha PC J Biomol Struct Dyn; 2019 Oct; 37(16):4181-4199. PubMed ID: 30648473 [No Abstract] [Full Text] [Related] [Next] [New Search]